Table 11.
Acarbose dose after titration | |||||
---|---|---|---|---|---|
0 | 50 | 100 | 150 | 200 | 300 |
-3(-6, -1)#m=49 | -4(-7, -3)#m=221 | -7(-8, -4)#m=211 | -7(-11, -1)#m=37 | ||
2(0, 4)#m=52 | -3(-8, 0)#m=34 | ||||
4(2, 6)#m=149 | 3(1, 6)#m=40 | -2(-6, 0)#m=72 | -2(-4, 0)#m=94 | ||
4(2, 6)#m=122 | 0(-1, 2)#m=65 | -2(-3, 0)#m=144 | |||
4(2, 7)#m=67 | 3(2, 6)#m=48 | -1(-3, 1)#m=75 | |||
7(4, 10)#m=82 | 7(3, 9)#m=49 | 3(2, 6)#m=92 |
Change in HbA1c values after acarbose initiation, titration, or discontinuation. The values above the diagonal represent the instances where the medication has been initiated or up-titrated, while the values below the diagonal represent instances where the medication has been down-titrated or discontinued. The values refer to the mean difference in HbA1c (MD) and 95% confidence intervals. MD below 0 indicate a lowering in HbA1c while those above 0 indicate an increase in HbA1c. #m refers to the number of HbA1c pairs for that dose titration